Update to Conflicts of Interest
There was an error in the original publication [1]. Alexander M. Seifalian and Amelia Seifalian did not declare the disclose a conflict of interest regarding their work on material developed by NanoRegMed Ltd.
A correction has been made to Conflicts of Interest Statement as below:
Alexander M. Seifalian is the co-founder and scientific director of NanoRegMed Ltd., as indicated in the affiliation. He and his research team have developed and patented a graphene-based nanocomposite material; trade registered as BioHastalex®. This has been highlighted in the manuscript as their current work in London. Amelia Seifalian is associated with NanoRegMed but does not hold a formal position or receive financial compensation from the company.
The authors state that the scientific conclusions are unaffected. This correction was approved by the Academic Editor. The original publication has also been updated.
Reference
- Aleemardani, M.; Zare, P.; Seifalian, A.; Bagher, Z.; Seifalian, A.M. Graphene-Based Materials Prove to Be a Promising Candidate for Nerve Regeneration Following Peripheral Nerve Injury. Biomedicines 2022, 10, 73. [Google Scholar] [CrossRef] [PubMed]
Disclaimer/Publisher’s Note: The statements, opinions and data contained in all publications are solely those of the individual author(s) and contributor(s) and not of MDPI and/or the editor(s). MDPI and/or the editor(s) disclaim responsibility for any injury to people or property resulting from any ideas, methods, instructions or products referred to in the content. |
© 2025 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/).